{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06088654",
            "orgStudyIdInfo": {
                "id": "IPH6501-101"
            },
            "organization": {
                "fullName": "Innate Pharma",
                "class": "INDUSTRY"
            },
            "briefTitle": "Phase1/2 Study of IPH6501 in Patients With Relapsed /Refractory B-Cell Non-Hodgkin Lymphoma",
            "officialTitle": "A Phase 1/2, Open-Label, Multicenter Trial Investigating the Safety, Tolerability, and Preliminary Antineoplastic Activity of IPH6501 in Patients With Relapsed and/or Refractory CD20-expressing Non-Hodgkin Lymphoma",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "study-of-in-patients-with-relapsed-refractory-b-cell-non-hodgkin-lymphoma"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-06",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-03-04",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2028-12-31",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2028-12-31",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-10-12",
            "studyFirstSubmitQcDate": "2023-10-12",
            "studyFirstPostDateStruct": {
                "date": "2023-10-18",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-06-11",
            "lastUpdatePostDateStruct": {
                "date": "2024-06-12",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Innate Pharma",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This is an international, first-in-human, multicenter, open-label Phase 1/2 study to evaluate the safety profile, tolerability of IPH6501, and determine the recommended phase 2 dose (RP2D) for patients with B-Cell non-Hodgkin lymphoma.",
            "detailedDescription": "In Phase 1 - Dose finding, patients with advanced histologically confirmed, documented CD20+ B-cell non-Hodgkin lymphoma (NHL) will be enrolled. The dose finding part will include 2 sub-parts: Dose escalation will determine the Maximum Tolerated Dose (MTD) or the highest tested dose, Dose assessment will determine RP2D.\n\nIn Phase 2 - Dose expansion, one or more cohorts will be selected with patients with subtypes of advanced histologically confirmed, documented CD20+ B-cell non-Hodgkin lymphoma."
        },
        "conditionsModule": {
            "conditions": [
                "Non Hodgkin Lymphoma"
            ],
            "keywords": [
                "ANKET\u00ae",
                "NK cell engager",
                "tetraspecific NK cell engager"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1",
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 184,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "IPH6501 monotherapy",
                    "type": "EXPERIMENTAL",
                    "interventionNames": [
                        "Drug: IPH6501"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "IPH6501",
                    "description": "phase 1 (dose finding) and phase 2 (dose expansion)",
                    "armGroupLabels": [
                        "IPH6501 monotherapy"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Safety and tolerability",
                    "description": "To evaluate the safety profile (including dose limiting toxicities (DLT(s), the maximum tolerated dose (MTD) or highest tested dose), tolerability and determine the recommended phase 2 dose (RP2D)",
                    "timeFrame": "From time of informed consent through treatment period and including the follow-up: up to 22 months"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Objective Response Rate (ORR)",
                    "description": "To investigate any preliminary antitumor activity",
                    "timeFrame": "From time of informed consent through treatment period and including the follow-up: up to 22 months"
                },
                {
                    "measure": "Duration Of Response (DoR)",
                    "description": "To investigate any preliminary antitumor activity",
                    "timeFrame": "From time of informed consent through treatment period and including the follow-up: up to 22 months"
                },
                {
                    "measure": "Progression Free Survival (PFS)",
                    "description": "To investigate any preliminary antitumor activity",
                    "timeFrame": "From time of informed consent through treatment period and including the follow-up: up to 22 months"
                },
                {
                    "measure": "Maximum Observed Plasma Concentration (Cmax)",
                    "description": "To characterize and evaluate the pharmacokinetic profile of IPH6501",
                    "timeFrame": "From time of informed consent through treatment period and including the follow-up: up to 22 months"
                },
                {
                    "measure": "Area Under the Plasma Concentration (AUC)",
                    "description": "To characterize and evaluate the pharmacokinetic profile of IPH6501",
                    "timeFrame": "From time of informed consent through treatment period and including the follow-up: up to 22 months"
                },
                {
                    "measure": "Incidence of antidrug antibodies (ADA) against IPH6501",
                    "description": "To evaluate the immunogenicity of IPH6501",
                    "timeFrame": "From time of informed consent through treatment period and including the follow-up: up to 22 months"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Main Inclusion criteria\n\n* Patients with advanced histologically confirmed, documented CD20+ B-cell non-Hodgkin's lymphoma (NHL) including the following types defined by WHO 2016: Diffuse Large B Cell Lymphoma (DLBCL); high grade; thymic; Follicular Lymphoma (FL); Mantle cell lymphoma (MCL); Marginal zone lymphoma (MZL)\n* Relapsed, progressive and/or refractory disease without established alternative therapy\n* Must have received at least 2 prior systemic therapies including at a minimum anti-CD20 antibody therapy (e.g., rituximab) potentially in combination with chemotherapy and/or relapsed after autologous stem cell rescue.\n* Eastern Cooperative Oncology Group (ECOG) performance status of \u2264 2\n* Adequate organ and hematological function\n* Able to provide a fresh biopsy from a safely accessible site (or historical biopsy), per investigator determination.\n\nMain Exclusion Criteria\n\n* Patients with another invasive malignancy in the last 2 years\n* Prior chemotherapy, immunotherapy or other anti-cancer therapy within less than 4 weeks before study drug administration.\n* Autologous stem cell transplant or treatment with CAR-T (Chimeric Antigen Receptor T-Cell) cell therapy within 100 days prior to first dose of study drug\n* Subjects with brain or subdural metastases are not eligible, nor those with history of central nervous system (CNS) lymphoma\n* Current or past history of CNS disease, such as stroke, epilepsy, CNS vasculitis, or neurodegenerative disease.\n* Known history of infection with human immunodeficiency virus (HIV) or hepatitis B or C\n* Major surgery within 4 weeks before the first dose of study drug\n* Comorbidities including diabetes, cardiovascular diseases, immunodeficiencies/autoimmune condition\n* Pregnant / breastfeeding woman",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Innate pharma",
                    "role": "CONTACT",
                    "phone": "+33430303030",
                    "email": "clinical.trials@innate-pharma.fr"
                }
            ],
            "locations": [
                {
                    "facility": "City of Hope",
                    "status": "RECRUITING",
                    "city": "Duarte",
                    "state": "California",
                    "zip": "91010",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Swetha Kambhapati, MD",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Swetha Kambhapati, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 34.13945,
                        "lon": -117.97729
                    }
                },
                {
                    "facility": "Cedars Sinai",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Los Angeles",
                    "state": "California",
                    "zip": "90048",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Akil Merchant, MD",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Akil Merchant, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 34.05223,
                        "lon": -118.24368
                    }
                },
                {
                    "facility": "Memorial Sloan Kettering Cancer Center",
                    "status": "RECRUITING",
                    "city": "New York",
                    "state": "New York",
                    "zip": "10065",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Lorenzo Falchi, MD",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Lorenzo Falchi, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.71427,
                        "lon": -74.00597
                    }
                },
                {
                    "facility": "Wollongong Private Hospital",
                    "status": "RECRUITING",
                    "city": "Wollongong",
                    "state": "New South Wales",
                    "zip": "2500",
                    "country": "Australia",
                    "contacts": [
                        {
                            "name": "Peter Presgrave, MD",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Peter Presgrave, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": -34.424,
                        "lon": 150.89345
                    }
                },
                {
                    "facility": "Monash Health",
                    "status": "RECRUITING",
                    "city": "Clayton",
                    "state": "Victoria",
                    "zip": "3168",
                    "country": "Australia",
                    "contacts": [
                        {
                            "name": "Gareth Gregory, MD",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Gareth Gregory, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": -37.91667,
                        "lon": 145.11667
                    }
                },
                {
                    "facility": "Peninsula Private Hospital",
                    "status": "RECRUITING",
                    "city": "Frankston",
                    "state": "Victoria",
                    "zip": "3910",
                    "country": "Australia",
                    "contacts": [
                        {
                            "name": "Patricia Walker, MD",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Patricia Walker, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": -38.14458,
                        "lon": 145.12291
                    }
                },
                {
                    "facility": "Centre Hospitalier Regional Universitaire de Lille",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Lille",
                    "country": "France",
                    "contacts": [
                        {
                            "name": "Franck Morschhauser, MD",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Franck Morschhauser, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 50.63297,
                        "lon": 3.05858
                    }
                },
                {
                    "facility": "Hospices Civils de Lyon",
                    "status": "RECRUITING",
                    "city": "Lyon",
                    "zip": "69002",
                    "country": "France",
                    "contacts": [
                        {
                            "name": "Emmanuel Bachy, MD",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Emmanuel Bachy, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 45.74848,
                        "lon": 4.84669
                    }
                },
                {
                    "facility": "Centre Hospitalier Universitaire de Nantes",
                    "status": "RECRUITING",
                    "city": "Nantes",
                    "country": "France",
                    "contacts": [
                        {
                            "name": "Benoit Tessoulin, MD",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Benoit Tessoulin, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 47.21725,
                        "lon": -1.55336
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000008223",
                    "term": "Lymphoma"
                },
                {
                    "id": "D000008228",
                    "term": "Lymphoma, Non-Hodgkin"
                }
            ],
            "ancestors": [
                {
                    "id": "D000009370",
                    "term": "Neoplasms by Histologic Type"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000008232",
                    "term": "Lymphoproliferative Disorders"
                },
                {
                    "id": "D000008206",
                    "term": "Lymphatic Diseases"
                },
                {
                    "id": "D000007160",
                    "term": "Immunoproliferative Disorders"
                },
                {
                    "id": "D000007154",
                    "term": "Immune System Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M11220",
                    "name": "Lymphoma",
                    "asFound": "Lymphoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M18828",
                    "name": "Lymphoma, B-Cell",
                    "relevance": "LOW"
                },
                {
                    "id": "M11222",
                    "name": "Lymphoma, Non-Hodgkin",
                    "asFound": "Non-Hodgkin Lymphoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12315",
                    "name": "Neoplasms by Histologic Type",
                    "relevance": "LOW"
                },
                {
                    "id": "M11225",
                    "name": "Lymphoproliferative Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M11203",
                    "name": "Lymphatic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M10206",
                    "name": "Immunoproliferative Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M10200",
                    "name": "Immune System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T3543",
                    "name": "Lymphosarcoma",
                    "asFound": "Lymphoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "T640",
                    "name": "B-cell Lymphoma",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BC15",
                    "name": "Blood and Lymph Conditions"
                },
                {
                    "abbrev": "BC20",
                    "name": "Immune System Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        }
    },
    "hasResults": false
}